I am probably a contrarian here but I would rather see the money spent on trials than a PR agency ..there isn’t a PR person or agency who is going to speed up the FDA or UK reviews of Leronlimab. They will come in when they come in. Once that happens you won’t need anyone to promote the drug in the press. If Leronlimab saves lives the media will be calling Cytodyn, not the other way around.